Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Gray

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Human Brain Mapping|February 3, 2004
Mapping the time course of nonconscious and conscious perception of fear: an integration of central and peripheral measuresLeanne M Williams, Belinda J Liddell, Jennifer Rathjen, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 2, 2006
Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discoveryArtem G Evdokimov, Matthew Pokross, Richard Walter, et al.
Journal of Chemical Information and Modeling|March 10, 2026
The Open Molecular Software Foundation (OMSF) and the Growing Role of Open Source Software in Molecular ModelingKarmen Čondić-Jurkić, Irfan Alibay, Woody Sherman, et al.
Eclinicalmedicine|March 28, 2024
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trialSuzana Margareth Lobo, Gaétan Plantefève, Girish Nair, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Human Brain Mapping|February 3, 2004
Mapping the time course of nonconscious and conscious perception of fear: an integration of central and peripheral measuresLeanne M Williams, Belinda J Liddell, Jennifer Rathjen, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 2, 2006
Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discoveryArtem G Evdokimov, Matthew Pokross, Richard Walter, et al.
Journal of Chemical Information and Modeling|March 10, 2026
The Open Molecular Software Foundation (OMSF) and the Growing Role of Open Source Software in Molecular ModelingKarmen Čondić-Jurkić, Irfan Alibay, Woody Sherman, et al.
Eclinicalmedicine|March 28, 2024
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trialSuzana Margareth Lobo, Gaétan Plantefève, Girish Nair, et al.
Pageof 2